Cencora, Inc. (COR) stock
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3022% above fair value
$349.88+1.17 (+0.34%)
Close on Nov 11, 2026Market cap $66.77BP/E 26.0Yield 0.63%
Cencora ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Cencora's ebitda for the twelve months ending Jun 30, 2026 was $4.08B. For fiscal 2025 it was $3.68B, up 12.6% from the year before. Over ten years it grew 18.6% a year on average. The highest annual figure on record is $3.68B in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.68B | +12.6% |
| FY2024 | Sep 30, 2024 | $3.27B | -1.1% |
| FY2023 | Sep 30, 2023 | $3.30B | +8.0% |
| FY2022 | Sep 30, 2022 | $3.06B | +7.0% |
| FY2021 | Sep 30, 2021 | $2.86B | – |
| FY2020 | Sep 30, 2020 | -$4.74B | -401.4% |
| FY2019 | Sep 30, 2019 | $1.57B | -17.5% |
| FY2018 | Sep 30, 2018 | $1.91B | +30.9% |
| FY2017 | Sep 30, 2017 | $1.46B | -22.9% |
| FY2016 | Sep 30, 2016 | $1.89B | +181.8% |
| FY2015 | Sep 30, 2015 | $670.86M | -30.9% |
| FY2014 | Sep 30, 2014 | $970.77M | -8.5% |
| FY2013 | Sep 30, 2013 | $1.06B | -26.2% |
| FY2012 | Sep 30, 2012 | $1.44B | +11.4% |
| FY2011 | Sep 30, 2011 | $1.29B | +9.8% |
| FY2010 | Sep 30, 2010 | $1.18B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $1.39B | +23.9% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $1.39B | +7.4% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $1.02B | +3.7% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $277.27M | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $1.12B | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $1.30B | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $984.75M | – |
See a number that looks wrong?